You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multiple Myeloma (MM)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Canton (Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Canton, Ohio
    Gabrail Cancer & Research Center
Oct 11, 2023

Multiple Myeloma Trial in Zwolle (e-coach multipel myeloma (MM))

Recruiting
  • Multiple Myeloma
  • e-coach multipel myeloma (MM)
  • Zwolle, Overijssel, Netherlands
    Isala Klinieken
Jul 26, 2023

Relapsed/ Refractory Multiple Myeloma Trial (GC012F)

Not yet recruiting
  • Relapsed/ Refractory Multiple Myeloma
  • GC012F
  • (no location specified)
Apr 28, 2023

Multiple Myeloma Trial in Montréal (Elranatamab)

Not yet recruiting
  • Multiple Myeloma
  • MontrĂ©al, Quebec, Canada
    McGill University Health Centre
Sep 21, 2023

Multiple Myeloma Trial in Salt Lake City (Budesonide EC, Placebo)

Not yet recruiting
  • Multiple Myeloma
  • Budesonide EC
  • Placebo
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Jan 9, 2023

Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)

Completed
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Anti-GPRC5D CAR-T Cells Injection)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T Cells Injection
  • (no location specified)
Feb 18, 2023

Medicine Called Elranatamab in People With Relapsed Refractory

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 30, 2023

Real-world Usage of HyQvia in Multiple Myeloma Secondary

Not yet recruiting
  • Multiple Myeloma
  • Secondary Immunodeficiency (SID)
  • No Intervention
  • (no location specified)
May 19, 2023

Multiple Myeloma Trial in Augusta (Lenalidomide, Vitamin D - Intensified, Vitamin D - Therapeutic)

Not yet recruiting
  • Multiple Myeloma
  • Augusta, Georgia
    Georgia Cancer Center at Augusta University
Apr 26, 2023

Immunophenotyping of Plasma Cells and Immune Effector Cells in

Not yet recruiting
  • Multiple Myeloma
  • Biological sampling
  • (no location specified)
Jun 17, 2022

Two Biologically and Clinically Distinct Entities: Progressive

Recruiting
  • Multiple Myeloma
  • +2 more
    • Miami, Florida
      University of Miami Hospitals
    Jun 7, 2022

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Kunming (Anti-GPRC5D CAR-T cells infusion)

    Recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • Anti-GPRC5D CAR-T cells infusion
    • Kunming, Yunnan, China
    • +1 more
    Feb 21, 2023

    Multiple Myeloma Trial in United States (Daratumumab, Lenalidomide, Bortezomib)

    Recruiting
    • Multiple Myeloma
    • Ann Arbor, Michigan
    • +3 more
    Jan 19, 2023

    Multiple Myeloma Trial (Elranatamab, Elotuzumab, Pomalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Nov 28, 2023

    Serum NGAL IN Patients With Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma(MM)
    • SERUM NGAL
    • (no location specified)
    Jun 26, 2022

    Learn About Medicine in People With Relapsed Refractory Multiple

    Completed
    • Multiple Myeloma
    • New York, New York
      Pfizer
    Nov 14, 2022

    Multiple Myeloma Trial in Tianjin (Autologous hematopoietic stem cell transplantation, C-CAR088)

    Recruiting
    • Multiple Myeloma
    • Autologous hematopoietic stem cell transplantation
    • C-CAR088
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Nov 21, 2022

    Multiple Myeloma Cells From miRNAs Released From B Cells, and

    Recruiting
    • Multiple Myeloma
      • Aviano, Pordenone, Italy
        Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
      Nov 23, 2023

      Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (dexamethasone, doxorubicin HCl, thalidomide)

      Completed
      • Multiple Myeloma and Plasma Cell Neoplasm
      • Buffalo, New York
        Roswell Park Cancer Institute
      Sep 30, 2022

      Acute Myeloid Leukemia (AML), Multiple Myeloma (MM) Trial (3x10(6) CART-38 cellls, 7x10(5) CART-38 cells, 7x10(6) CART-38 cells)

      Not yet recruiting
      • Acute Myeloid Leukemia (AML)
      • Multiple Myeloma (MM)
      • 3x10(6) CART-38 cellls
      • +5 more
      • (no location specified)
      Jul 15, 2022

      Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

      Active, not recruiting
      • Multiple Myeloma
      • Torino, Italy
        Fondazione EMN Italy Onlus
      Mar 24, 2022

      Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)

      Active, not recruiting
      • Multiple Myeloma
      • Torino, Italy
        Fondazione EMN Italy Onlus
      Mar 24, 2022

      Learn How Triple Class Refractory Multiple Myeloma Are Treated

      Not yet recruiting
      • Relapse Multiple Myeloma
      • Refractory Multiple Myeloma
        • (no location specified)
        Feb 15, 2023

        Multiple Myeloma Trial (REGN5458)

        Available
        • Multiple Myeloma
        • (no location specified)
        Dec 9, 2021